Determination of Reactive Oxygen Species in Myringotomized Tympanic Membranes: Effect of Vitamin E Treatment

Laryngoscope

Volumn 114, Issue 4, 2004, Pages 720-725

  Polat, Senol ^a,b   Öztürk, Özmen ^a   Üneri, Cüneyd ^a   Yüksel, Meral ^a   Haklar, Goncagül ^a   Bozkurt, Süheyla ^a   Küllü, Sevgi ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Free radicals; Myringotomy; Reactive oxygen species; Tympanosclerosis; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; LUMINOL; OLIVE OIL; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHEMICAL ANALYSIS; CHEMOLUMINESCENCE; CONTROLLED STUDY; EAR DISEASE; EARDRUM; HISTOLOGY; MICROSCOPY; MIDDLE EAR MUCOSA; MYRINGOSCLEROSIS; MYRINGOTOMY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RAT; SCLEROSIS; TYMPANOSCLEROSIS; ANIMAL; DRUG EFFECT; EVALUATION; METABOLISM; MIDDLE EAR VENTILATION; PATHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; MIDDLE EAR VENTILATION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SCLEROSIS; TYMPANIC MEMBRANE; VITAMIN E;

EID: 1842610130     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200404000-00023     Document Type: Article

References (38)

1. Mattsson C, Magnuson K, Hellström S. Myringotomy: a prerequisite for the development of myringosclerosis. Laryngoscope 1998;108:102-106.
2. Tos M, Stangerup S-E. Hearing loss in tympanosclerosis caused by grommets. Arch Otolaryngol Head Neck Surg 1989;115:931-935.
3. Riley DN, Herberger S, McBride G, Law K. Myringotomy and ventilation tube insertion: a ten year follow up. J Laryngol Otol 1997;111:257-261.
4. Koc A, Uneri C. Sex distribution in children with tympanosclerosis after insertion of a tympanostomy tube. Eur Arch Otorhinolaryngol 2001;258:16-19.
5. Bhaya MH, Schachern PA, Morizono T, Paparella MM. Pathogenesis of tympanosclerosis. Otolaryngol Head Neck Surg 1993;109:413-420.
6. Costa SS, Paparella MM, Scachern PA, Yoon TH, Kimberley BP. Temporal bone histopathology in chronically infected ears with intact and perforated tympanic membranes. Laryngoscope 1992;102:1229-1236.
7. Schiff M, Poliquin JF, Catanzaro A, Ryan AF. Tympanosclerosis: a theory of pathogenesis. Ann Otol Rhinol Laryngol 1980;89(Suppl 70):1-15.
8. Koc A, Uneri C. Genetic predisposition for tympanosclerotic degeneration. Eur Arch Otorhinolaryngol 2002;259:180-183.
9. Mattsson C, Magnuson K, Hellström S. Myringosclerosis caused by increased oxygen concentration in traumatized tympanic membranes. Ann Otol Rhinol Laryngol 1995;104: 625-632.
10. Mattsson C, Marklund SL, Hellström S. Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol 1997;106: 513-518.
11. Spratley JE, Hellström S, Mattsson C, Pais-Clemente M. Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. Ann Otol Rhinol Laryngol 2001;110:585-591.
12. Niki E. Antioxidants in relation to lipid peroxidation. Chem Phys Lipids 1987;44:227-253.
13. Ozcan C, Gorur K, Cinel L, Talas DU, Unal M, Cinel I. The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Pediatr Otorhinolaryngol 2002;63:179-184.
14. Dalaman G, Haklar G, Sipahioǧlu A, Ozener C, Akoglu E, Yalcin S. Early diagnosis of peritonitis in continuous ambulatory peritoneal dialysis patients by chemiluminescence: evaluation of diagnostic accuracy by ROC curve analysis. Clin Chem 1998;44:1680-1684.
15. Boveris A, Cadenas E, Reiter R, Filipkowski M, Nakase Y, Chance B. Organ chemiluminescence: non-invasive assay for oxidative radical reactions. Proc Natl Acad Sci U S A 1980;77:347-351.
16. Davies GR, Simmonds NJ, Stevens TR, et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994;35:179-185.
17. Felding JU, Rasmussen JB, Lildholdt T. Gas composition of the normal and ventilated middle ear cavity. Scan J Lab Invest 1987;47(Suppl 186):31-41.
18. Mover-Lev H, Sade J, Ar A. Rate of gas exchange in the middle ear of guinea pigs. Ann Otol Rhinol Laryngol 1998;107:194-198.
19. Buckingham RA, Stuart DS, Girgis SJ, Maurine G, McGee TJ. Experimental evidence against middle ear oxygen absorption. Laryngoscope 1985;95:437-442.
20. Mattsson C, Johansson C, Hellström S. Myringosclerosis develops within 9 hour of myringotomy. ORL J Otorhinolaryngology Relat Spec 1999;61:31-36.
21. Parks RR, Huang C-C, Haddad J. Evidence of oxygen radical injury in experimental otitis media. Laryngoscope 1994;104:1389-1392.
22. Takoudes TG, Haddad J. Lipid peroxides in the middle ear fluid after acute otitis media in guinea pigs. Ann Otol Rhinol Laryngol 1999;108:564-568.
23. Takoudes TG, Haddad J. Hydrogen peroxide in acute otitis media in guinea pigs. Laryngoscope 1997;107:206-210.
24. Haddad J. Lipoperoxidation as a measure of free radical injury in otitis media. Laryngoscope 1998;108:524-530.
25. Takoudes TG, Haddad J. Free radical production by antibiotic-killed bacteria in the guinea pig middle ear. Laryngoscope 2001;111:283-289.
26. Halliwell B, Gutteridge JMC, eds. Free Radicals in Biology and Medicine, 3rd ed. New York, NY: Oxford University Press, Inc., 2000.
27. Gutteridge JM, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990;15:129-135.
28. Dahle LK, Hill EG, Holman RT. The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters. Arch Biochem Biophys 1962;98:253-261.
29. Southorn PA, Powis G. Free radicals in medicine, I: Chemical nature and biologic reactions. Mayo Clin Proc 1988;63:381-389.
30. Van Dyke K, Castranova V, eds. Cellular Chemiluminescence. London: CRC Press; 1987:1-67.
31. Allen RC, Loose LD. Phagocytic activation of a luminol-dependent chemiluminescence in rabbit alveolar and peritoneal macrophages. Biochem Biophys Commun 1976;69:45-53.
32. Chen C, Liu FK, Qi XP, Li JS. The study of chemiluminescence in gastric and colonic carcinoma cell lines treated by anti-tumor drugs. World J Gastroenterol 2003;9:242-245.
33. McCord JM. Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem 1993;26:351-357.
34. Yoshida Y, Niki E, Noguchi N. Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects. Chem Phys Lipids 2003;123:63-75.
35. Owen RW, Giacosa A, Hull WE, et al. Olive-oil consumption and health: the possible role of antioxidants. Lancet Oncol 2000;1:107-112.
36. Visioli F, Bellomo G, Galli C. Free radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun 1998;247:60-64.
37. Visioli F, Poli A, Gall C. Antioxidant and other biological activities of phenols from olives and olive oil. Med Res Rev 2002;22:65-75.
38. Cabrini L, Barzanti V, Cipollone M, et al. Antioxidants and total peroxyl radical-trapping ability of olive and seed oils. J Agric Food Chem 2001;49:6026-6032.